ArticleFrontiers in public health2026
Predicting 30-day readmission using DRG-based hospitalization data: a large real-world logistic regression model from a tertiary hospital.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of dual-time-window readmission prediction models under China's medical insurance multi-payment reform.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early unplanned readmission is a key quality indicator in Diagnosis-Related Groups (DRG)-based payment systems. Despite China's rapid expansion of DRG reform, evidence on hospital-wide predictors of 30-day readmission using large-scale real-world data from tertiary hospitals remains limited. This study developed and evaluated a DRG-based logistic regression model for predicting 30-day readmission. Methods: We conducted a single-center retrospective study using administrative hospitalization data from a high-volume tertiary hospital in Shanghai, China. We extracted 65,215 inpatient episodes from the hospital (January 2023-December 2024). After excluding discharges in December 2024 due to incomplete follow-up ( Results: The 30-day readmission rate was 13.0%. In unadjusted comparisons, patients who were readmitted had shorter median hospital stays (3 vs. 4 days) and lower total costs. After multivariable adjustment, longer length of stay was associated with increased readmission risk (OR 1.016 per day, Conclusion: Using comprehensive DRG-based real-world data, we developed an interpretable prediction model for 30-day readmission with moderate-to-good discrimination and acceptable calibration. Clinical case-mix captured by DRG categories and patient-level complexity reflected by longer length of stay were key determinants of early readmission. The model may support risk stratification, quality improvement, and performance monitoring in DRG payment environments. The findings may also inform policy discussions on aligning DRG efficiency incentives with patient safety outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.